Las publicaciones de mayor impacto de la semana en 29 especialidades, seleccionadas por IA
Última actualización: 11 may 2026
Publicado: 2026-12-01
Annals of medicine
MediLens Indexado: 2026-05-12
This study investigates the variation in ischemic stroke admissions among patients with atrial fibrillation (AF) based on the day of the week. Analyzing data from the nationwide FinACAF study, which included 13,781 patients with a mean age of 79.2 years, the results show significant differences i...
Leer en PubMedPublicado: 2026-05-11
Hypertension (Dallas, Tex. : 1979)
MediLens Indexado: 2026-05-12
The WISDOM-HMOD study evaluated the relationship between nighttime blood pressure measured by a wrist-type monitor and left ventricular hypertrophy in 1218 patients with hypertension or heart failure. Results showed an average nighttime systolic/diastolic BP of 110.5±13.0/63.5±8.8 mm Hg, with 70....
Leer en PubMedPublicado: 2026-05-11
Circulation. Heart failure
MediLens Indexado: 2026-05-12
This review addresses the significant advancements in cardiac gene therapy for cardiomyopathy, highlighting the transition of adeno-associated virus-mediated gene replacement into early-phase clinical trials. It notes improvements in biomarkers like NT-proBNP and discusses the challenges in deliv...
Leer en PubMedPublicado: 2026-05-11
Medical science monitor : international medical journal of experimental and clinical research
MediLens Indexado: 2026-05-12
This study evaluated the impact of a structured, multidisciplinary case management model on cardiac function and glycemic control in elderly patients with coronary heart disease and diabetes undergoing off-pump CABG. A total of 168 patients were randomized to receive either routine care or an enh...
Leer en PubMedPublicado: 2026-05-11
Cardiology in review
MediLens Indexado: 2026-05-12
This study highlights the critical role of sodium-glucose cotransporter 2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists in reducing cardiovascular and kidney disease risks in patients with type 2 diabetes. Empagliflozin showed significant benefits in reducing cardiovascular m...
Leer en PubMedMédicos de todo el mundo comienzan su mañana con revisiones de literatura curadas por IA, entregadas a las 7 AM.
Prueba gratuita de 7 días